Physician profile
Jeffrey Branta
NPI 1083933261
$1,221.68
in general payments reported to CMS, 2019-2025
15 companies · $612 in 2025
The $612 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.53 · 2022: $31.30 · 2023: $121 · 2024: $444 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $461.45 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $260.50 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $128.14 | 2023-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $72.48 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Astrazeneca Pharmaceuticals LP | $69.74 | 2024 | Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $53.83 | 2025 | |
| Merck Sharp & Dohme LLC | $48.70 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Dexcom, INC. | $22.37 | 2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $18.26 | 2025 | Gemtesa |
| Edwards Lifesciences Corporation | $14.93 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi Pasteur INC. | $14.82 | 2025 | |
| Currax Pharmaceuticals LLC | $14.42 | 2025 | Contrave |
| Amgen INC. | $14.37 | 2025 | Repatha, Otezla |
| Sobi, INC | $14.14 | 2022 | |
| Abbott Laboratories | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Branta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.